bioavailability is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-04-14. Where a claim depends on a specific study, the study is described rather than over-claimed.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Investigational status in most countries |
| Sports status | Prohibited by WADA | Classified as non-approved or metabolic modulator |
| Common analytical method | LC-MS/MS | Used for trace detection in biological samples |
| Typical test matrices | Urine and blood | Sample choice depends on testing program |
| Human trial data | None published | Effects and safety are not established |
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
However, extensive root colonization still occurs in these plants and these hallmarks of resistance seem to diminish by about day 21 after colonization, implying that EcM fungi can suppress the defense response. As the fungus and plant become closely connected, they begin to share nutrients. This process is also controlled by symbiosis-related genes. For example, monosaccharide uptake in Amanita muscaria requires a transporter that is only expressed when it is in a mycorrhizal association. When the transporter is expressed, leading to increased import of sugar by the fungus, the plant host responds by increasing sugar availability. The transport of ammonium and amino acids from fungus to plant is also regulated.
==== PC reception ==== Upon its retail release, Counter-Strike received highly favorable reviews. The New York Times reported that E-Sports Entertainment ESEA League started the first professional fantasy e-sports league in 2004 with the game Counter-Strike. Some credit the move into professional competitive team play with prizes as a major factor in Counter-Strike's longevity and success. The game was praised by critics for its emphasis on teamwork and communication among players. Scott Osborne, writing for GameSpot, felt that the audio messages were a decent feature, which covered requests for backup, status reports and warnings. One problem, according to him, was that both teams used the same voice. Clayton Wolfe of IGN expressed the importance of teamwork and stating, "It's the team-based tactics that make [Counter-Strike] so fun." Computer Games Magazine's Bill Hiles also commented about the social aspects of the game, saying that a player should work in teams rather than alone. Joe Dodson for GameRevolution wrote that "Nothing can beat a coordinated, experienced team in [Counter-Strike], except an even more coordinated and experienced team." He also found the team talk favorable. Most reviewers agreed that the GoldSrc engine felt dated, but still praised the graphics. Hiles commented that the visuals were acceptable and "do an admirable job portraying outdoor locations", while Dodson noted the graphics were identical to Half-Life.
GC-interface (combustion or pyrolysis) is also an online preparation method followed by IRMS detection. This is a 'compound-specific' method, allowing separation of analytes prior to measurement and thus providing information about the isotopic composition of each individual compound. After GC separation, samples are converted to smaller gaseous molecules for isotope measurements. GC/pyrolysis uses the pyrolysis interface between GC and IRMS for the conversion of H and O in the molecules into H2 and CO. GC-IRMS was first introduced by Matthews and Hayes in the late 1970s, and was later used for δ13C, δ15N, δ18O and δ34S. Helium is used as the carrier gas in the GC systems. However, the separation of DH (m/z=3) signal from the tail of 4He+ beam was problematic due to the intense signal of 4He+. During the early 1990s, intense efforts were made in solving the difficulties to measure δD by GC/pyrolysis-IRMS. In 1999, Hilkert et al. developed a robust method by integrating the high temperature conversion (TC) into GC-IRMS and adding a pre-cup electrostatic sector and a retardation lens in front of the m/z=3 cup collector. Several different groups were working on this at the same time. This GC/pyrolysis-IRMS based on TC has been widely used for δD measurement nowadays. The commercial products of GC-IRMS include both combustion and pyrolysis interfaces so that δ13C and δD can be measured simultaneously. The significant advantage of GC/pyrolysis method for HIC measurement is that it can separate different compounds in the samples.
Sources: en.wikipedia.org
=== Canada === In March 2002, Whirlpool announced it would close its last manufacturing facility in Canada, the Inglis plant in Montmagny, Quebec, by 2004, terminating 500 workers and shifting production to facilities in Tulsa, Oklahoma and Oxford Mississippi.
=== Hybridisation and polyploidy === Like common wheat, spelt is a hexaploid wheat species, which means it has six sets of chromosomes. It is derived from a hybridisation event between a domesticated tetraploid wheat such as durum wheat and another wheat species, increasing the number of sets of chromosomes. Genetic evidence indicates an initial hybridisation of a domesticated tetraploid wheat and the diploid wild goat-grass Aegilops tauschii. It further shows that spelt could have arisen as the result of a second hybridisation, this time of bread wheat and emmer, giving rise to European spelt. The spelt genome continues to influence the breeding of modern hexaploid bread wheat through recent hybridisation.
college sports) SOD (i/a) School Of Dentistry Statement Of Difference(s) Statement Of Direction Statement Of Documentation Statement Of Duty/Duties SOE (i) Secret Of Evermore Special Operations Executive (WWII British organization) State Of Emissions (EW) SOF (a/i) Special Operations Force(s) Status of Forces SOFIA – (a) Stratospheric Observatory For Infrared Astronomy SOGAT (a) Society of Graphical and Allied Trades Former British printing union SOHC – (i) Single-OverHead-Cam engine SOHO – (p) Solar and Heliospheric Observatory SOI (i) Signal Operating Instruction (i) Southern Oscillation Index SOL – (i) Shit Out of Luck SOLIS – (i) Synoptic Optical Long-term Investigations of the Sun som – (s) Somali language (ISO 639-2 code) SOM (a) Simulation Object Model (s) Somalia (ISO 3166 trigram) Sonar – (p) SOund Navigation And Ranging SOP (i) Standing/Standard Operating Procedure State of Play SOR (i) State Of Readiness Statement Of Requirements SOS (s) Somali shilling (ISO 4217 currency code) Save Our Souls SOSTAR – (a) Stand-Off Surveillance and Target Acquisition Radar sot – (s) Sotho language (ISO 639-2 code) SOUTHAG – (p) Southern Army Group SOUTHCOM – (p) (U.S.) Southern Command SOV – (i) Single Occupant Vehicle SOW – (i) Statement Of Work SOWHAT – (p) RESNA Subcommittee on Wheelchairs and Transportation SOX – (p) Sarbanes–Oxley Act
Robertson published his findings in the British Medical Journal in 1916 and, with the help of a few like-minded individuals (including the eminent physician Edward William Archibald), was able to persuade the British authorities of the merits of blood transfusion. Robertson went on to establish the first blood-transfusion apparatus at a Casualty Clearing Station on the Western Front in the spring of 1917. Robertson did not test crossmatching so that one died of hemolysis in his 1916 transfusion, and three in 1917. Oswald Hope Robertson, a medical researcher and U.S. Army officer, was attached to the RAMC in 1917, where he became instrumental in establishing the first blood banks in preparation for the anticipated Third Battle of Ypres. He used sodium citrate as the anticoagulant; blood was extracted from punctures in the vein and was stored in bottles at British and American Casualty Clearing Stations along the Front. Robertson also experimented with preserving separated red blood cells in iced bottles. Geoffrey Keynes, a British surgeon, developed a portable machine that could store blood to enable transfusions to be carried out more easily.
Sources: en.wikipedia.org
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.
Sports authorities prohibit it because it is not approved for human use and has potential performance-enhancing effects. It appears on anti-doping lists under non-approved or metabolic modulator categories.
Detection usually uses liquid chromatography-tandem mass spectrometry. The method targets the parent compound or its metabolites in urine or blood.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.